PHI granted patent on synthetic antibodies in the EU
Phase Holographic Imaging (PHI) announces that the Company has been granted a patent on synthetic antibodies from the European Patent Office. The patent application “EP329447 Molecularly Imprinted Polymers” was submitted by PHI together with Germany’s Federal Institute for Materials Research (BAM). PHI’s corresponding patents in the US and Japan were granted in 2020 and 2022, respectively. In spring 2023, PHI established the